Palvella Therapeutics任命罕见病商业领袖Jennifer J. Mcdonough为市场准入与患者服务高级副总裁,强化领导团队

美股速递
Mar 23

Palvella Therapeutics宣布了一项重要人事任命,罕见病领域的商业领袖Jennifer J. Mcdonough已加入公司,担任市场准入与患者服务高级副总裁。这一举措旨在加强公司的领导团队实力。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10